Adel Nada

Adel Nada

Company: GentiBio

Job title: Co-Founder, President, CEO


Engineered Tregs as a Therapeutic Modality 9:30 am

Scalable technology to generate robust phenotype of engineered Tregs is critically needed to address many autoimmune and antiinflammatory disorders TCR and CAR antigen specific Tregs enable optimal efficacy and safety of engineered TregsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.